Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 217,794 shares at $96.79 ($21.7M) on 2019-08-13, disclosed to the SEC on 2019-08-14.
Open-market sale of $21.7M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.79 | 2,400 | $232K | 1.1% |
| 2 | $97.83 | 11,813 | $1.2M | 5.3% |
| 3 | $98.96 | 44,446 | $4.4M | 20.3% |
| 4 | $99.83 | 158,529 | $15.8M | 73.0% |
| 5 | $101.30 | 606 | $61K | 0.3% |
| Total | $99.51 avg | 217,794 |
| $21.7M |
| 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |